ProCE Banner Activity

Expert Audio From Germany and the UK on Strategies to Reduce HCV Incidence in Key Populations

Audio

This on-demand audio features expert perspectives on HCV elimination efforts in Germany and the UK and highlights globally applicable lessons on treatment as prevention.

Released: May 14, 2019

Expiration: May 12, 2020

Share

Faculty

Graham R. Foster

Graham R. Foster, FRCP, PhD

Professor of Hepatology
The Liver Unit
Consultant Hepatologist
Queen Mary University of London
London, United Kingdom

Heiner Wedemeyer

Heiner Wedemeyer, MD

Professor and Chairman
Department of Gastroenterology, Hepatology and Endocrinology
Hannover Medical School
Hannover, Germany

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by an educational grant from

Gilead

Partners

INHSU

ProCE Banner

Program Director Disclosure

Program Director

Graham R. Foster, FRCP, PhD

Professor of Hepatology
The Liver Unit
Consultant Hepatologist
Queen Mary University of London
London, United Kingdom

Graham R. Foster, FRCP, PhD, has disclosed that he has received consulting fees from AbbVie, Gilead Sciences, GlaxoSmithKline, Merck, and Roche and has ownership interest in GlaxoSmithKline.

Faculty Disclosure

Primary Author

Heiner Wedemeyer, MD

Professor and Chairman
Department of Gastroenterology, Hepatology and Endocrinology
Hannover Medical School
Hannover, Germany

Heiner Wedemeyer, MD, has disclosed that he has received consulting fees from Abbott, AbbVie, Bristol-Myers Squibb, Gilead Sciences, Janssen, MSD/Merck, and Roche and funds for research support from Abbott, AbbVie, and Gilead Sciences.